| http://www.w3.org/ns/prov#value | - Ridker and colleagues noted some limitations of their analysis, including the use of a single statin at a single dose, the fact that all participants had elevated high-sensitivity C-reactive protein, and the relatively short duration of follow-up (median 2 years), which precludes a long-term assessment of the risk-benefit balance.
|
